Charles Rhyee
Stock Analyst at TD Cowen
(1.12)
# 3,563
Out of 4,761 analysts
50
Total ratings
33.33%
Success rate
-12.03%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $127.06 | +13.33% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $163.02 | +39.25% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $14.88 | +68.01% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $11.51 | -30.50% | 6 | Oct 31, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $369 → $285 | $201.39 | +41.52% | 3 | Oct 25, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $413 → $372 | $340.22 | +9.34% | 3 | Oct 23, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $225.79 | -14.97% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.81 | +232.64% | 7 | May 16, 2024 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.01 | +66.39% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $11.74 | +325.89% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $191.04 | +31.39% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $5.22 | +972.80% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.69 | +1,928.99% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $10.43 | +379.39% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $597.71 | -39.60% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.59 | +203,417.59% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $18.61 | +88.07% | 1 | Feb 13, 2018 |
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $127.06
Upside: +13.33%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $163.02
Upside: +39.25%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $14.88
Upside: +68.01%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $11.51
Upside: -30.50%
ICON Public Limited Company
Oct 25, 2024
Maintains: Buy
Price Target: $369 → $285
Current: $201.39
Upside: +41.52%
Medpace Holdings
Oct 23, 2024
Maintains: Buy
Price Target: $413 → $372
Current: $340.22
Upside: +9.34%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $225.79
Upside: -14.97%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.81
Upside: +232.64%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.01
Upside: +66.39%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $11.74
Upside: +325.89%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $191.04
Upside: +31.39%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $5.22
Upside: +972.80%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.69
Upside: +1,928.99%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $10.43
Upside: +379.39%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $597.71
Upside: -39.60%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.59
Upside: +203,417.59%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $18.61
Upside: +88.07%